Treatment for peichori(urticaria) - An oral administration of siddha medicine peichori chooranam

Effectiveness Of PEICHORI CHOORANAM In Management Of PEICHORI (URTICARIA) - A Case Series - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072816

Enrollment

Registered

2024-08-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L509- Urticaria, unspecified

Interventions

Intervention1: Peichori chooranam: Dosage: 1-2 gms twice a day orally for 30 days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presenting with itching, wheal formation, swelling 2. Patient willing to attend OPD for 30 days 3. Patient willing to give blood sample for laboratory investigation

Exclusion criteria

Exclusion criteria: 1. Narcotic addicts 2. Pregnancy and lactation 3. Diabetes mellitus 4. Hypertension 5. Evidence of any skin condition other than urticaria

Design outcomes

Primary

Measure	Time frame
Prognosis of peichori (urticaria) will be assessed by clinical symptoms, blood investigation and urticaria activity score of the patients ( before and after treatment)Timepoint: 30 DAYS	—

Secondary

Measure	Time frame
Not applicableTimepoint: Not applicable	—

Countries

India

Contacts

Public ContactDR M P ABDUL KADER JEYLANI

Government Siddha Medical College and Hospital, Palayamkottai

chenthamaraianand@gmail.com9443652074

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026